Brief: Asit Biotech: Yves Désiront To Replace Everard Van Der Straten As Interim CFO
Jan 16 (Reuters) - ASIT BIOTECH SA ASIT.BR :
* YVES DÉSIRONT TO REPLACE EVERARD VAN DER STRATEN AS
INTERIM CFO
* MICHEL BAIJOT IS NOW LEADING COMPANY AS NEW CEO TOWARDS
ITS
REASSESSED STRATEGIC GOALS FOR 2019 AND ONWARDS
* ONGOING RESTRUCTURING OF ASIT BIOTECH ORGANIZATION TO
MAXIMIZE
SUCCESS OF GP-ASIT+™ IN GRASS POLLEN RHINITIS
* PHILIPPE DEGEER TO JOIN BOARD OF DIRECTORS AS
REPRESENTATIVE OF
MEUSINVEST
Source text for Eikon: ID:nBw5MjYdka
Further company coverage: ASIT.BR
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com;))
Recent news on European Medical Solutions SA
See all newsBrief: DMS Imaging H1 EBITDA Rises To EUR 2.2 Million
Brief: DMS Imaging Announces Resumption Of Project To Transfer Its Listing Securities On Euronext Growth Market In Paris And Brussels
Brief: DMS Imagining Announces End Of Litigation With Thierry Legon
Brief: DMS Imaging Sees 2023 Revenue At 40 Million Euros
Brief: DMS Imaging Says Fujifilm Healthcare Italy Wins Tender For Its Radiology Tables